Literature DB >> 10434952

Cardiotoxicity of cancer therapy.

K A Tolba1, E N Deliargyris.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10434952     DOI： 10.3109/07357909909021433

Source DB:  PubMed          Journal:  Cancer Invest        ISSN： 0735-7907            Impact factor:   2.176


× No keyword cloud information.
  14 in total

Review 1.  Consolidation/maintenance chemotherapy for ovarian cancer.

Authors:  Maurie Markman
Journal:  Curr Oncol Rep       Date:  2003-11       Impact factor: 5.075

Review 2.  Second malignant neoplasms and cardiovascular disease following radiotherapy.

Authors:  Lois B Travis; Andrea K Ng; James M Allan; Ching-Hon Pui; Ann R Kennedy; X George Xu; James A Purdy; Kimberly Applegate; Joachim Yahalom; Louis S Constine; Ethel S Gilbert; John D Boice
Journal:  J Natl Cancer Inst       Date:  2012-02-06       Impact factor: 13.506

3.  Recognizing the toxicity of "nontoxic" drugs employed in the management of malignant disease.

Authors:  Maurie Markman
Journal:  Curr Oncol Rep       Date:  2007-09       Impact factor: 5.075

4.  Pregnancy-associated cardiomyopathy in survivors of childhood cancer.

Authors:  Melissa R Hines; Daniel A Mulrooney; Melissa M Hudson; Kirsten K Ness; Daniel M Green; Scott C Howard; Matthew Krasin; Monika L Metzger
Journal:  J Cancer Surviv       Date:  2015-06-05       Impact factor: 4.442

5.  Career readiness in adult survivors of childhood cancer: a report from the St. Jude Lifetime Cohort Study.

Authors:  David Strauser; James L Klosky; Tara M Brinkman; Alex W K Wong; Fong Chan; Jennifer Lanctot; Rohit P Ojha; Leslie L Robison; Melissa M Hudson; Kirsten K Ness
Journal:  J Cancer Surviv       Date:  2014-07-22       Impact factor: 4.442

Review 6.  Cardiotoxicity in childhood cancer survivors: strategies for prevention and management.

Authors:  Danielle Harake; Vivian I Franco; Jacqueline M Henkel; Tracie L Miller; Steven E Lipshultz
Journal:  Future Cardiol       Date:  2012-07

7.  Deficits in physical function among young childhood cancer survivors.

Authors:  Megan C Hoffman; Daniel A Mulrooney; Julia Steinberger; Jill Lee; K Scott Baker; Kirsten K Ness
Journal:  J Clin Oncol       Date:  2013-06-24       Impact factor: 44.544

8.  Subsequent Breast Cancer in Female Childhood Cancer Survivors in the St Jude Lifetime Cohort Study (SJLIFE).

Authors:  Matthew J Ehrhardt; Carrie R Howell; Karen Hale; Malek J Baassiri; Carol Rodriguez; Carmen L Wilson; Surekha S Joshi; Thomas C Lemond; Sheila Shope; Rebecca M Howell; Zhaoming Wang; Deokumar Srivastava; Daniel A Mulrooney; Jinghui Zhang; Leslie L Robison; Kirsten K Ness; Melissa M Hudson
Journal:  J Clin Oncol       Date:  2019-05-10       Impact factor: 44.544

9.  Metabolic syndrome and cardiovascular risk among long-term survivors of acute lymphoblastic leukaemia - From the St. Jude Lifetime Cohort.

Authors:  Kerri A Nottage; Kirsten K Ness; Chenghong Li; Deokumar Srivastava; Leslie L Robison; Melissa M Hudson
Journal:  Br J Haematol       Date:  2014-01-27       Impact factor: 6.998

10.  The role of ROS in ionizing radiation-induced VLA-4 mediated adhesion of RAW264.7 cells to VCAM-1 under flow conditions.

Authors:  Ye Yuan; Shin Hee Lee; Shiyong Wu
Journal:  Radiat Res       Date:  2012-11-26       Impact factor: 2.841
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.